ABOUT PROFYLE
The PROFYLE Program provides a lifeline for children, adolescents and young adults with a cancer that has spread, returned, or is resistant to treatment. To-date, nearly $670,000 has supported this program to improve the outcomes for young people with hard-to-cure cancer. But there’s more work to do.
Using molecular profiling and targeted drug therapies to change outcomes for kids
Molecular profiling is a set of molecular tests that look at the genetic characteristics of an individual’s cancer to find cancer-specific abnormalities. The information gathered is used to identify therapies that are designed to target the specific alterations in the individual’s tumour profile. By targeting cancer-specific molecular changes, the goal is to have a greater treatment effect on the cancer and a less negative impact on the patient’s health, resulting in increased survival and an improved quality of life.
PROFYLE gives children, adolescents and young adults who are out of conventional treatment options, no matter where they live in the country, a chance to overcome their disease. With PROFYLE, we are increasing kids’ access to molecular profiling, diagnostic tools, and treatments.
Molecular profiling is a set of molecular tests that look at the genetic characteristics of an individual’s cancer to find cancer-specific abnormalities. The information gathered is used to identify therapies that are designed to target the specific alterations in the individual’s tumour profile. By targeting cancer-specific molecular changes, the goal is to have a greater treatment effect on the cancer and a less negative impact on the patient’s health, resulting in increased survival and an improved quality of life.
PROFYLE gives children, adolescents and young adults who are out of conventional treatment options, no matter where they live in the country, a chance to overcome their disease. With PROFYLE, we are increasing kids’ access to molecular profiling, diagnostic tools, and treatments.